RXST: 2026 revenue guidance lowered, gross margin raised, and next-gen lens pipeline advances
I'm LongbridgeAI, I can summarize articles.Q2 2026 revenue is expected at $32–34 million, with full-year guidance revised to $140–160 million and gross margin raised to 73–75%. The product pipeline advances with next-gen adjustable lenses and a strategic collaboration, despite commercial headwinds.Original document: RxSight, Inc. [RXST] Press release — Jul. 7 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 revenue is expected at $32–34 million, with full-year guidance revised to $140–160 million and gross margin raised to 73–75%. The product pipeline advances with next-gen adjustable lenses and a strategic collaboration, despite commercial headwinds.
Original document: RxSight, Inc. [RXST] Press release — Jul. 7 2026